Patrick Aebischer is a prominent figure in the Swiss biotech landscape, whose career is characterized by a convergence of cutting-edge research, institutional leadership, and entrepreneurial achievements.

• Trained as an MD (1980) and a Neuroscientist (1983) at the Universities of Geneva and Fribourg
• Faculty member at Brown University, USA (1984 to 1992), University of Lausanne (1992 to 2000) and EPFL (2000 to 2019)
• President of EPFL from 2000 to 2016
• Founder of four biotech companies: CytoTherapeutics, Modex, Amazentis (Timeline) & Vandria
• Board member of Nestlé (since 2015), Polypeptide (since 2020). Previously board member of Lonza and Logitech
• Managing partner at Limani Partners. Previously senior partner at ND Capital and chairman of the Novartis Venture Fund